Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 19, Issue 4, 2005, Pages 459-467

  Chandler, Wayne L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Blood loss; Cardiopulmonary bypass; Coagulation; Consumption; Hemodilution

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN; D DIMER; FIBRINOGEN; FIBRINOPEPTIDE A; FIBROLASE; PLASMIN; PLASMINOGEN; PROTHROMBIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FIBRIN FORMATION; HEMODILUTION; HEMOSTASIS; HUMAN; MALE; PATIENT; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

AGED; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; COMPUTER SIMULATION; FIBRINOGEN; HEMODILUTION; HEMOSTASIS; HUMANS; LIVER; MALE; MIDDLE AGED; PLASMINOGEN; PROTHROMBIN; RISK FACTORS;

EID: 23444439487     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2004.11.046     Document Type: Article

References (70)

1. G.J. Despotis, M.S. Avidan, C.W.J. Hogue Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann Thorac Surg 72 2001 S1821 S1831
2. P. Bruins, H. te Velthuis, A.P. Yazdanbakhsh Activation of the complement system during and after cardiopulmonary bypass surgery, postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia Circulation 96 1997 3542 3548
3. M. Cugno, J. Nussberger, P. Biglioli Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass The importance of lung exclusion Chest 120 2001 1776 1782
4. H. Teufelsbauer, S. Proidl, M. Havel Early activation of hemostasis during cardiopulmonary bypass Evidence for thrombin-mediated hyperfibrinolysis Thromb Haemost 68 1992 250 252
5. M.D. Boisclair, D.A. Lane, H. Philippou Mechanisms of thrombin generation during surgery and cardiopulmonary bypass Blood 82 1993 3350 3357
6. G. Valen, E. Eriksson, B. Risberg Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood Eur J Cardiothorac Surg 8 1994 324 330
7. G.J. Despotis, J.H. Joist, C.W.J. Hogue More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT Thromb Haemost 76 1996 902 908
8. A.B. Gelb, R.I. Roth, J. Levin Changes in blood coagulation during and following cardiopulmonary bypass Lack of correlation with clinical bleeding Am J Clin Pathol 106 1996 87 99
9. B.J. Hunt, R.N. Parratt, H.C. Segal Activation of coagulation and fibrinolysis during cardiothoracic operations Ann Thorac Surg 65 1998 712 718
10. L.A. Harker, T.W. Malpass, H.E. Branson Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass Acquired transient platelet dysfunction associated with selective alpha-granule release Blood 56 1980 824 834
11. W.L. Chandler, T. Velan Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass Blood 101 2003 4355 4362
12. M.J. Ray, N.A. Marsh Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin Thromb Haemost 78 1997 1021 1026
13. H. Pelzer, A. Schwarz, W. Stuber Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide Thromb Haemost 65 1991 153 159
14. H. Pelzer, A. Schwarz, N. Heimburger Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay Thromb Haemost 59 1988 101 106
15. R. Bos, G.H. Laterveer-Vreeswijk, D. Lockwood A new enzyme immunoassay for soluble fibrin in plasma with a high discriminating power for thrombotic disorders Thromb Haemost 81 1999 54 59
16. 2-antiplasmin complex in human plasma-application to the detection of in vivo activation of the fibrinolytic system Thromb Haemost 56 1986 124 127
17. M.J. Elms, I.H. Bunce, P.G. Bundesen Measurement of crosslinked fibrin degradation products, an immunoassay using monoclonal antibodies Thromb Haemost 50 1983 591 594
18. J. Gram, J. Jespersen Improved assay of antithrombin-III. Effects of certain additives on thrombin and chromogenic peptide substrates Clin Chem 31 1985 1683 1688
19. B. Mulloy, E. Gray, T.W. Barrowcliffe Characterization of unfractionated heparin Comparison of materials from the last 50 years Thromb Haemost 84 2000 1052 1056
20. A.C. Teger-Nilsson, P. Friberger, E. Gyzander Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin-specific tripeptide substrate Scand J Clin Lab Invest 37 1977 403 409
21. A. Clauss Gerinnungsphysiologische Schnellmethode zu Bestimmung des Fibrinogens Acta Haematol 17 1957 237 245
22. J. Amiral, J.M. Walenga, J. Fareed Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A Semin Thromb Hemost 10 1984 228 242
23. N.S. Jenny, K.G. Mann Thrombin R.W. Colman J. Hirsh V.J. Marder Hemostasis and Thrombosis Basic Principles and Clinical Practice (ed 4) 2001 JB Lippincott Company Philadelphia, PA 171 189
24. S.A. Bock Antithrombin III and heparin cofactor II W. Colman J. Hirsh V.J. Marder Hemostasis and Thrombosis Basic Principles and Clinical Practice (ed 4) 2001 JB Lippincott Company Philadelphia, PA 321 333
25. R.R. Hantgan, C.W. Francis, V.J. Marder Fibrinogen structure and physiology W. Colman J. Hirsh V.J. Marder Hemostasis and Thrombosis Basic Principles and Clinical Practice (ed 4) 1994 JB Lippincott Company Philadelphia, PA 277 300
26. F. Bachmann Plasminogen-plasmin enzyme system R.W. Colman J. Hirsh V.J. Marder Hemostasis and Thrombosis Basic Principles and Clinical Practice (ed 4) 2001 JB Lippincott Company Philadelphia, PA 276 320
27. L.H. Edmunds Hemostatic problems in surgical patients J.N. George Hemostasis and Thrombosis Basic Principles and Clinical Practice (ed 4) 2001 JB Lippincott Company Philadelphia, PA 1031 1043
28. J.J. Franks, R.E. Kirsch, B. Kao Fibrinogen and fibrinogen-related peptides in cancer G. Mariani Pathophysiology of Plasma Protein Metabolism 1984 Plenum Press New York, NY 265 278
29. K.A. Bauer, T.L. Goodman, B.L. Kass Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency J Clin Invest 76 1985 826 836
30. C.W. Francis, V.J. Marder Physiologic regulation and pathologic disorders of fibrinolysis R.W. Colman J. Hirsh V.J. Marder Hemostasis and Thrombosis. Basic Principles and Clinical Practice (ed 4) 2001 JB Lippincott Philadelphia, PA 975 1002
31. W.L. Chandler, M.C. Alessi, M.F. Aillaud Formation, inhibition and clearance of plasmin in vivo Haemostasis 30 2000 204 218
32. H.L. Nossel, I. Yudelman, R.E. Canfield Measurement of fibrinopeptide A in human blood J Clin Invest 54 1974 43 53
33. W.L. Chandler, W.C. Levy, R.C. Veith A kinetic model of the circulatory regulation of tissue plasminogen activator during exercise, epinephrine infusion, and endurance training Blood 81 1993 3293 3302
34. W.L. Chandler, W.C. Levy, J.R. Stratton The circulatory regulation of TPA and UPA secretion, clearance and inhibition during exercise and during the infusion of isoproterenol and phenylephrine Circulation 92 1995 2984 2994
35. D. Keber, A. Blinc, J. Fettich Increase of tissue plasminogen activator in limbs during venous occlusion A simple haemodynamic model Thromb Haemost 64 1990 433 437
36. E. Witzleb Functions of the vascular system R.F. Schmidt G. Thews Human Physiology 1983 Springer Verlag New York, NY 397 455
37. W.L. Chandler, M.C. Alessi, M.F. Aillaud Clearance of TPA and TPA/PAI-1 complex Relationship to elevated TPA antigen in patients with high PAI-1 activity levels Circulation 96 1997 761 768
38. W.L. Chandler, T. Velan Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass Thromb Res 112 2004 185 192
39. T. Velan, W.L. Chandler Effects of surgical trauma and cardiopulmonary bypass on active thrombin concentrations and the rate of thrombin inhibition in vivo Pathophysiol Haemostas Thromb 33 2004 144 156
40. M.J. Eisses, K. Seidel, G.S. Aldea Reducing hemostatic activation during cardiopulmonary bypass A combined approach Anesth Analg 98 2004 1208 1216
41. W.W. Hampton, M.C. Townsend, W.J. Schirmer Effective hepatic blood flow during cardiopulmonary bypass Arch Surg 124 1989 458 459
42. D.L. Higgins, S.D. Lewis, J.A. Shafer Steady-state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin J Biol Chem 258 1983 9276 9282
43. J. Jesty The kinetics of inhibition of alpha-thrombin in human plasma J Biol Chem 261 1986 10313 10318
44. S.A. Bock Antithrombin III and heparin cofactor II W. Colman Hemostasis and Thrombosis Basic Principles and Clinical Practice (ed 4) 2001 JB Lippincott Company Philadelphia, PA 321 333
45. J.A. Marcum, J.B. McKenney, R.D. Rosenberg Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium J Clin Invest 74 1984 341 350
46. M. Shifman, S. Pizzo The in vivo metabolism of antithrombin III and antithrombin III complexes J Biol Chem 257 1982 3243 3248
47. B. Leonard, R. Bies, T. Carlson Further studies of the turnover of dog antithrombin III. Study of 131I-labelled antithrombin protease complexes Thromb Res 30 1983 165 177
48. W.L. Chandler, J.C.K. Fitch, M.H. Wall Individual variations in the fibrinolytic response during and after cardiopulmonary bypass Thromb Haemost 74 1995 1293 1297
49. M. Spannagl, G. Dooijewaard, W. Dietrich Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin-treated cardiac surgical patients undergoing cardiopulmonary bypass Thromb Haemost 73 1995 825 828
50. S. Thorsen The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis Ann N Y Acad Sci 667 1992 52 63
51. J.W. Weisel, Y. Veklich, J.P. Collet Structural studies of fibrinolysis by electron and light microscopy Thromb Haemost 82 1999 277 282
52. 2-antiplasmin and leupeptin Biochem J 275 1991 53 59
53. 2-antiplasmin and plasmin, stopped-flow fluorescence kinetics FEBS Lett 387 1996 58 62
54. J. Amiral, F. Minard, V. Plassart Reactivity of D-dimer assays with the fibrinogen-fibrin split products generated by thrombolytic agents Blood Coagul Fibrinolysis 1 1990 525 530
55. A. Kornberg, C.W. Francis, V.J. Marder Plasma crosslinked fibrin polymers Quantitation based on tissue plasminogen activator conversion to D-dimer and measurement of normals and patients with acute thrombotic disorders Blood 80 1992 709 717
56. K. Kolev, I. Léránt, K. Tenekejiev Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors J Biol Chem 269 1994 17030 17034
57. W.L. Chandler, T. Velan Plasmin generation and D-dimer formation during cardiopulmonary bypass Blood Coagul Fibrinolysis 15 2004 583 591
58. A.K. Chan, M. Leaker, F.A. Burrows Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass Thromb Haemost 77 1997 270 277
59. G.S. Aldea, X. Zhang, C.A. Memmolo Enhanced blood conservation in primary coronary artery bypass surgery using heparin-bonded circuits with lower anticoagulation J Card Surg 11 1996 85 92
60. G.S. Aldea, L.O. Soltow, W.L. Chandler Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits J Thorac Cardiovasc Surg 123 2002 742 755
61. B. Eberle, E. Mayer, G. Hafner High-dose α-aminocaproic acid versus aprotinin antifibrinolytic efficacy in first-time coronary operations Ann Thorac Surg 65 1998 667 673
62. H. Nishida, S. Aomi, Y. Tomizawa Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass Artif Organs 23 1999 547 551
63. Y. Niimi, F. Ichinose, Y. Ishiguro The effects of heparin coating of oxygenator fibers on platelet adhesion and protein adsorption Anesth Analg 89 1999 573 579
64. J.F. Keuren, S.J. Wielders, G.M. Willems Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood Thromb Haemost 87 2002 742 747
65. M.R. Williams, A.B. D'Ambra, J.R. Beck A randomized trial of antithrombin concentrate for treatment of heparin resistance Ann Thorac Surg 70 2000 873 877
66. T.F. Slaughter, J.B. Mark, H. El-Moalem Hemostatic effects of antithrombin III supplementation during cardiac surgery Results of a prospective randomized investigation Blood Coagul Fibrinolysis 12 2001 25 31
67. M. Rossi, L. Martinelli, S. Storti The role of antithrombin III in the perioperative management of the patient with unstable angina Ann Thorac Surg 68 1999 2231 2236
68. G. Marx, H. Pokar, H. Reuter The effects of aprotinin on hemostatic function during cardiac surgery J Cardiothor Vasc Anesth 5 1991 467 474
69. D. Higgins, S. Lewis, J. Shafer Steady-state kinetic parameters for the thrombin catalyzed conversion of human fibrinogen to fibrin J Biol Chem 258 1983 9276 9282
70. M. Picozzi, R. De Cristofaro Effect of temperature on the association step in thrombin-fibrinogen interaction Biochem J 294 1993 563 567